Christopher Wraight
Amministratore Delegato presso MecRx Pty Ltd.
Posizioni attive di Christopher Wraight
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
MecRx Pty Ltd.
 MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Amministratore Delegato | - | - |
Storia della carriera di Christopher Wraight
Precedenti posizioni note di Christopher Wraight
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Direttore Tecnico/Scientifico/R&S | 06/11/2009 | 31/08/2010 |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Amministratore Delegato | 25/11/2013 | - |
| Direttore operativo | 01/01/2011 | 25/11/2013 |
Formazione di Christopher Wraight
| LaTrobe University | Doctorate Degree |
| Chifley Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Australia | 6 |
Posizioni
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Otifex Therapeutics Pty Ltd.
Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Health Technology |
MecRx Pty Ltd.
MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Health Technology |
- Borsa valori
- Insiders
- Christopher Wraight
- Esperienza
